☆ 4.7 Article

Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center

JOURNAL OF CLINICAL MEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Hematology

Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing

Athina Tampaki et al.

Summary: SCD is a common inherited clinical syndrome characterized by anemia, susceptibility to infections, and vaso-occlusive crisis. Studies have investigated the role of complement activation in SCD pathophysiology, with eculizumab showing beneficial effects. The review summarizes the current understanding and potential therapeutic perspectives of complement system activation in SCD.

BLOOD REVIEWS (2021)

添加到收藏夹

Meeting Abstract Hematology

Humoral and T Cell Immune Responses to Sars-Cov-2 Vaccination in Hematopoietic Cell Transplant Recipients

Eleni Gavriilaki et al.

BLOOD (2021)

添加到收藏夹

Article Medical Laboratory Technology

Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign

Davide Ferrari et al.

Summary: This study evaluated the immune response to the first vaccine dose in different sex/age groups and individuals with or without naturally present anti-SARS-CoV-2 antibodies. Naturally seropositive individuals showed stronger vaccine response and longer antibody persistence compared to seronegative individuals. The importance of serological tests in identifying individuals with pre-existing immunity and evaluating vaccine-induced immunity was highlighted.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

添加到收藏夹

Article Hematology

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Yair Herishanu et al.

Summary: Patients with chronic lymphocytic leukemia have a significantly impaired antibody response to the BNT162b2 mRNA COVID-19 vaccine, which is influenced by disease activity and treatment.

BLOOD (2021)

添加到收藏夹

Article Hematology

BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies

Katrin Herzog Tzarfati et al.

Summary: Patients with hematologic malignancies have a reduced immune response to the COVID-19 vaccine, with lower seropositivity rates and antibody titers, increasing their risk for severe infection.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹

Letter Hematology

Serologic response to mRNA COVID-19 vaccination in lymphoma patients

Eric Matthew Jurgens et al.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹

Article Hematology

Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy

Binod Dhakal et al.

BLOOD (2021)

添加到收藏夹

Letter Medicine, General & Internal

Antibody response after second BNT162b2 dose in allogeneic HSCT recipients

Rabah Redjoul et al.

LANCET (2021)

添加到收藏夹

Editorial Material Hematology

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma

Sean H. Lim et al.

LANCET HAEMATOLOGY (2021)

添加到收藏夹

Review Hematology

Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review

Usama Waqar et al.

Summary: This review explored the pathophysiology, epidemiology, diagnosis, management, and prognosis of thrombosis with thrombocytopenia syndrome (TTS) following vaccination with AZD1222 or Ad26.COV2.S. Most patients were female with a median age of 42.5 years, and majority developed cerebral venous sinus thrombosis. The mortality rate was 36.2%, with patients in severe conditions more likely to die than recover.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Willingness of Greek general population to get a COVID-19 vaccine

Georgia Kourlaba et al.

Summary: The study examined the willingness of adult residents in Greece to receive a COVID-19 vaccine, with only 57.7% of respondents stating they would get vaccinated. Factors such as age, vulnerability to the virus, beliefs about its origins, perceptions of its severity compared to other viruses, and knowledge score on COVID-19 were significantly associated with willingness to get vaccinated.

GLOBAL HEALTH RESEARCH AND POLICY (2021)

添加到收藏夹

Review Medicine, Research & Experimental

The 2020 race towards SARS-CoV-2 specific vaccines

Tomasz M. Karpinski et al.

Summary: The global outbreak of COVID-19 has emphasized the urgent need for effective vaccines and treatments. Advances in biotechnology and genetic engineering have provided progress in understanding the virus, with the development of vaccines being a key focus. Challenges in vaccine development and distribution, as well as the importance of safety and long-term effectiveness, have also been highlighted.

THERANOSTICS (2021)

添加到收藏夹

Article Hematology

Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy

Lubka T. Roumenina et al.

AMERICAN JOURNAL OF HEMATOLOGY (2020)

添加到收藏夹

Review Hematology

Innate immune cells, major protagonists of sickle cell disease pathophysiology

Slimane Allali et al.

HAEMATOLOGICA (2020)

添加到收藏夹

Letter Hematology

COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient

Frans Beerkens et al.

AMERICAN JOURNAL OF HEMATOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition

Efthymia Vlachaki et al.

HEMOGLOBIN (2018)

添加到收藏夹

Letter Hematology

In vitro evidence of complement activation in patients with sickle cell disease

Eleni Gavriilaki et al.

HAEMATOLOGICA (2017)

添加到收藏夹

Review Medicine, General & Internal

Sickle cell disease

Russell E. Ware et al.

LANCET (2017)

添加到收藏夹

Letter Hematology

In vitro evidence of complement activation in patients with sickle cell disease

Eleni Gavriilaki et al.

HAEMATOLOGICA (2017)

添加到收藏夹

Article Oncology

Assessing the Immunogenic Response of a Single Center's Pneumococcal Vaccination Protocol in Sickle Cell Disease

Jonathan D. Santoro et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2016)

添加到收藏夹

Review Medicine, General & Internal

Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members

Barbara P. Yawn et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know

Rakhi P. Naik et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.